PT  - JOURNAL ARTICLE
AU  - Muthaffar, Osama Y.
TI  - Treating epilepsy with options other than antiepileptic medications
AID  - 10.17712/nsj.2020.4.20200010
DP  - 2020 Aug 01
TA  - Neurosciences Journal
PG  - 253--261
VI  - 25
IP  - 4
4099  - http://nsj.org.sa/content/25/4/253.short
4100  - http://nsj.org.sa/content/25/4/253.full
SO  - Neurosciences (Riyadh)2020 Aug 01; 25
AB  - Epilepsy is a common health burden worldwide. Epilepsy is linked to variety of factors, including infectious, vascular, immune, structural, genetic, and metabolic etiologies. Despite the existence of multiple antiepileptic drugs (AEDs), many patients are diagnosed with intractable epilepsy. Many nonpharmacological options are available for epilepsy. Some types of epilepsy respond to cofactors. Other patients may be candidates for a ketogenic diet. Inflammatory mediators, such as intravenous immunoglobulins (IVIgs) and steroids, are other options for epilepsy. Recently, cannabinoids have been approved for epilepsy treatment. Refractory epilepsy can be treated with surgical interventions. Focal resections, hemispherectomies, and corpus callosotomies are some common epilepsy surgery approaches. Neuromodulation techniques are another option. Thermal ablation is a minimally invasive approach for epilepsy treatment. Epilepsy outcomes are improving, and treatment modalities are expanding. Trials of nonpharmacological options for epilepsy patients are recommended. This article summarizes available nonpharmacological options other than AEDs for the treatment of epilepsy.